Stay updated on Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.2.0 on the page, indicating a minor site update. No changes to study content or layout were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T14:45:00.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The government funding/NIH operating status banner was removed from the page.
    Difference
    0.3%
    Check dated 2025-11-18T07:28:15.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    No additions or deletions were detected; only metadata updates (e.g., the 'Results First Posted' date) and minor formatting/UI refinements. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T21:12:56.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Added a funding/operating status notice and a new version tag (v3.2.0); removed two specific cancer diagnoses and an older version tag (v3.1.0).
    Difference
    2%
    Check dated 2025-10-06T08:48:39.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no other page content or data appears to be altered.
    Difference
    0.0%
    Check dated 2025-09-29T07:35:00.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed, with no substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-14T23:13:03.000Z thumbnail image

Stay in the know with updates to Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.